Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study.
Saved in:
| Title: | Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study. |
|---|---|
| Authors: | Bakouny, Z.1 (AUTHOR), Labaki, C.1 (AUTHOR), Bhalla, S.1,2 (AUTHOR), Schmidt, A.L.1 (AUTHOR), Steinharter, J.A.1 (AUTHOR), Cocco, J.2 (AUTHOR), Tremblay, D.A.2 (AUTHOR), Awad, M.M.1 (AUTHOR), Kessler, A.2 (AUTHOR), Haddad, R.I.1 (AUTHOR), Evans, M.3 (AUTHOR), Busser, F.1 (AUTHOR), Wotman, M.3 (AUTHOR), Curran, C.R.1 (AUTHOR), Zimmerman, B.S.2 (AUTHOR), Bouchard, G.1 (AUTHOR), Jun, T.2 (AUTHOR), Nuzzo, P.V.1 (AUTHOR), Qin, Q.2 (AUTHOR), Hirsch, L.1 (AUTHOR) |
| Source: | Annals of Oncology. Aug2022, Vol. 33 Issue 8, p836-844. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
